SYS-CON MEDIA Authors: Gilad Parann-Nissany, PR.com Newswire, RealWire News Distribution, Scott Kinka, Kevin Benedict

News Feed Item

Free Research Reports on BIOF, HLF, LOGM and PCYC Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY -- (Marketwire) -- 02/18/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

BioFuel Energy Corp. (NASDAQ: BIOF) shares gained 22.36 percent to close at $6.73 a share Friday. The stock, which averages 202,126 shares traded a day, traded 1.77 million shares Friday, more than eight times the average daily volume.

Find out more about BioFuel Energy including full access to the free equity report at: www.BedfordReport.com/BIOF

Herbalife Ltd. (NYSE: HLF) shares spiked sharply in early trading Friday and traded over three times its average daily volume. Billionaire investor Carl Icahn has recently disclosed he has accumulated a 13 per cent stake in the company.

Find out more about Herbalife including full access to the free equity report at: www.BedfordReport.com/HLF

LogMeIn Inc. (NASDAQ: LOGM) shares plunged 30 percent on over 7 million shares traded Friday. The company reported a GAAP income of $3.6 million for the fiscal year 2012, compared to a net income of $5.8 million in fiscal 2011. The company forecast of earnings in the range of $0.43 to $0.49 per diluted share in fiscal 2013 fell short of analysts' estimates.

Find out more about LogMeIn including full access to the free equity report at: www.BedfordReport.com/LOGM

Pharmacyclics, Inc. (NASDAQ: PCYC) shares hit a new 52-week high of $87.82 and gained 8.47 percent on over four times the average daily volume Friday after reporting quarterly results. To date, the Company has received three milestone payments from Janssen of $50 million each.

Find out more about Pharmacyclics including full access to the free equity report at: www.BedfordReport.com/PCYC

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.